These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35917244)

  • 21. Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.
    Krentz AJ; Fujioka K; Hompesch M
    Diabetes Obes Metab; 2016 Jun; 18(6):558-70. PubMed ID: 26936802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs to treat overweight and obesity.
    J Psychosoc Nurs Ment Health Serv; 2013 Aug; 51(8):9-10. PubMed ID: 23938009
    [No Abstract]   [Full Text] [Related]  

  • 23. Drugs to treat overweight and obesity.
    J Psychosoc Nurs Ment Health Serv; 2014 Aug; 52(8):21-2. PubMed ID: 25106053
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
    Tak YJ; Lee SY
    Curr Obes Rep; 2021 Mar; 10(1):14-30. PubMed ID: 33410104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fat pill for teens. Xenical may have the FDA's blessing, but is it a good idea?
    Gupta S
    Time; 2003 Dec 29-2004 Jan 5; 162(26):162. PubMed ID: 14722944
    [No Abstract]   [Full Text] [Related]  

  • 26. The FDA's assessment of two drugs for chronic weight management.
    Colman E; Golden J; Roberts M; Egan A; Weaver J; Rosebraugh C
    N Engl J Med; 2012 Oct; 367(17):1577-9. PubMed ID: 23050510
    [No Abstract]   [Full Text] [Related]  

  • 27. The fat of the matter.
    Nat Med; 2012 Aug; 18(8):1155. PubMed ID: 22869166
    [No Abstract]   [Full Text] [Related]  

  • 28. Past and present of antiobesity agents: focus on monoamine modulators.
    Khorassani FE; Misher A; Garris S
    Am J Health Syst Pharm; 2015 May; 72(9):697-706. PubMed ID: 25873617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Updates on obesity pharmacotherapy.
    Velazquez A; Apovian CM
    Ann N Y Acad Sci; 2018 Jan; 1411(1):106-119. PubMed ID: 29377198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrave--a combination of bupropion and naltrexone for weight loss.
    Med Lett Drugs Ther; 2014 Nov; 56(1455):112-4. PubMed ID: 25372849
    [No Abstract]   [Full Text] [Related]  

  • 31. Is there a path for approval of an antiobesity drug: what did the Sibutramine Cardiovascular Outcomes Trial find?
    Downey M; Still C; Sharma AM
    Curr Opin Endocrinol Diabetes Obes; 2011 Oct; 18(5):321-7. PubMed ID: 21878755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The FDA's risk/benefit calculus in the approvals of Qsymia and Belviq: treating an obesity epidemic while avoiding another fen-phen.
    Azebu LM
    Food Drug Law J; 2014; 69(1):87-111, ii-iii. PubMed ID: 24772687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug treatment of obesity.
    Bray GA; Ryan DH
    Psychiatr Clin North Am; 2011 Dec; 34(4):871-80. PubMed ID: 22098810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are there guidelines to evaluate claims made for weight-loss products?
    Cunningham E
    J Acad Nutr Diet; 2014 Jun; 114(6):976. PubMed ID: 24857675
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological treatment of obesity in Europe: waiting for the arrival of the white blackbird.
    Rubio MA
    Endocrinol Nutr; 2014 Dec; 61(10):501-4. PubMed ID: 25434595
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological therapies for obesity.
    Kaplan LM
    Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significant FDA approvals in 1999.
    McGinnis TJ
    Am Fam Physician; 2000 Apr; 61(8):2531-3. PubMed ID: 10794586
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacotherapy for psychotropic drug-related weight gain.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2008 Jul; 46(7):15-8. PubMed ID: 18686592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy for Patients with Obesity.
    Gadde KM; Apolzan JW; Berthoud HR
    Clin Chem; 2018 Jan; 64(1):118-129. PubMed ID: 29054924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy for the Treatment of Overweight and Obesity in Children, Adolescents, and Young Adults in a Large Health System in the US.
    Czepiel KS; Perez NP; Campoverde Reyes KJ; Sabharwal S; Stanford FC
    Front Endocrinol (Lausanne); 2020; 11():290. PubMed ID: 32477270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.